<DOC>
	<DOC>NCT00971776</DOC>
	<brief_summary>The AB Portable Driver System will allow patients supported with the Circulatory Support System to be discharged home when their medical condition improves to an ambulating status and will continue to receive the assistance of the AB 5000 ventricle for their heart recovery.</brief_summary>
	<brief_title>Voyager I: Patient Discharge Using the AB5000 Portable Driver System</brief_title>
	<detailed_description />
	<criteria>The subject is an AB5000 Circulatory Support System patient (in accordance FDAapproved indications for use) who is suffering acute cardiac dysfunction and is potentially recoverable; The subject is male or female, age 18 years or older; The subject is able to ambulate unassisted; The subject is on stable oral anticoagulation over 7 days (INR 24) with no active bleeding; The subject is willing and able to read, understand and sign the study specific informed consent form; The subject agrees to comply with study protocol requirements, including all followup visits and completion of Qol and NIH stroke scale assessments. The subject, predevice implant, is qualified as a transplant candidate. There is an absence of a trained companion. There is an absence of a psychosocial support. The subject has an inadequate home environment, such as poor access which may hinder movements. The subject has experienced hypotension in last 24 hours based on two consecutive readings spaced by 8 hours with systolic blood pressures &lt; 90 mmHg. The subject requires respiratory assistance. The subject has an active infection (positive blood culture and/or body T ≥ 38 degrees C, and/or WBC ≥ 12K/µL). The subject requires tube feeding. The subject has any other medical condition requiring hospitalization.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Patient receiving AB5000 ventricle potentially recoverable</keyword>
</DOC>